Cargando…
Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma?
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983034/ https://www.ncbi.nlm.nih.gov/pubmed/21120197 http://dx.doi.org/10.5045/kjh.2010.45.3.143 |
_version_ | 1782191791847505920 |
---|---|
author | Lee, Je-Jung |
author_facet | Lee, Je-Jung |
author_sort | Lee, Je-Jung |
collection | PubMed |
description | |
format | Text |
id | pubmed-2983034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-29830342010-11-30 Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma? Lee, Je-Jung Korean J Hematol Editorial Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2010-09 2010-09-30 /pmc/articles/PMC2983034/ /pubmed/21120197 http://dx.doi.org/10.5045/kjh.2010.45.3.143 Text en © 2010 The Korean Journal of Hematology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Lee, Je-Jung Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma? |
title | Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma? |
title_full | Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma? |
title_fullStr | Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma? |
title_full_unstemmed | Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma? |
title_short | Soluble syndecan-1 (CD138): is it useful as a prognostic factor in Korean patients with multiple myeloma? |
title_sort | soluble syndecan-1 (cd138): is it useful as a prognostic factor in korean patients with multiple myeloma? |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2983034/ https://www.ncbi.nlm.nih.gov/pubmed/21120197 http://dx.doi.org/10.5045/kjh.2010.45.3.143 |
work_keys_str_mv | AT leejejung solublesyndecan1cd138isitusefulasaprognosticfactorinkoreanpatientswithmultiplemyeloma |